Impact of Heart Failure Guideline Publication on Medicare Drug Coverage Policies: A Quasi‐Experimental Analysis
Coverage barriers to ARNI and SGLT2i were common and changed only slightly after publication of Value Statements in HF guidelines. There is a critical need for robust strategies to improve access to life-saving HF medications.
Authors
- Samrachana Adhikari (ORCID: https://orcid.org/0000-0001-9954-5999)
- Rishi K. Wadhera (ORCID: https://orcid.org/0000-0003-1089-3896)
- Tyrel Stokes (ORCID: https://orcid.org/0000-0001-9305-1859)
- Donglan Zhang (ORCID: https://orcid.org/0000-0001-5225-4721)
- Harmony R. Reynolds (ORCID: https://orcid.org/0000-0003-0284-0655)
- Allison Patricia Squires (ORCID: https://orcid.org/0000-0002-5238-2122)
- Amrita Mukhopadhyay (ORCID: https://orcid.org/0000-0002-7768-459X)
- Stuart D. Katz (ORCID: https://orcid.org/0000-0003-2340-2021)
- Aparna Narendrula (ORCID: https://orcid.org/0000-0003-0986-9004)
- Saul Blecker (ORCID: https://orcid.org/0000-0003-4460-1046)
- Nathalia Ladino
Institutions
- KES College (CY)
- Health Foundation (GB)
- Meyer (China) (CN)
- Deaconess Hospital (US)
- New York University (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1161/jaha.125.043610
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 0.00